AIF-1 plays therefore an important role in the pathogenesis of RA by affecting key processes such as the activation of synovial cell proliferation and the inflammatory cytokine cascade including IL-6 in joints and may represent a new molecular target in RA therapy. Here, IL6 is linked to rheumatoid arthritis.